Mackay Shields LLC Has $7.23 Million Holdings in Agilent Technologies, Inc. (NYSE:A)

Mackay Shields LLC lowered its stake in Agilent Technologies, Inc. (NYSE:AGet Rating) by 2.6% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 45,285 shares of the medical research company’s stock after selling 1,187 shares during the quarter. Mackay Shields LLC’s holdings in Agilent Technologies were worth $7,230,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of the company. D Orazio & Associates Inc. bought a new stake in shares of Agilent Technologies in the 3rd quarter valued at $30,000. Larson Financial Group LLC bought a new position in Agilent Technologies during the 4th quarter worth about $39,000. CVA Family Office LLC bought a new position in Agilent Technologies during the 4th quarter worth about $41,000. Asset Dedication LLC bought a new position in shares of Agilent Technologies in the 4th quarter valued at about $42,000. Finally, Amplius Wealth Advisors LLC bought a new position in shares of Agilent Technologies in the 4th quarter valued at about $42,000.

Shares of A opened at $126.44 on Monday. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.64 and a current ratio of 2.19. Agilent Technologies, Inc. has a 52-week low of $123.06 and a 52-week high of $179.57. The business’s 50 day moving average price is $133.68 and its two-hundred day moving average price is $145.57. The firm has a market cap of $37.98 billion, a PE ratio of 32.09, a price-to-earnings-growth ratio of 2.89 and a beta of 1.05.

Agilent Technologies (NYSE:AGet Rating) last issued its earnings results on Tuesday, February 22nd. The medical research company reported $1.21 earnings per share for the quarter, topping analysts’ consensus estimates of $1.17 by $0.04. Agilent Technologies had a return on equity of 27.04% and a net margin of 18.70%. The company had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.66 billion. During the same period in the prior year, the firm earned $1.06 earnings per share. Agilent Technologies’s revenue for the quarter was up 8.1% on a year-over-year basis. Research analysts predict that Agilent Technologies, Inc. will post 4.86 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 27th. Stockholders of record on Tuesday, April 5th will be paid a dividend of $0.21 per share. The ex-dividend date is Monday, April 4th. This represents a $0.84 annualized dividend and a dividend yield of 0.66%. Agilent Technologies’s payout ratio is 21.32%.

In other Agilent Technologies news, SVP Michael Tang sold 1,210 shares of the firm’s stock in a transaction dated Friday, March 18th. The stock was sold at an average price of $136.21, for a total value of $164,814.10. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Several equities research analysts recently issued reports on A shares. Bank of America cut their target price on shares of Agilent Technologies from $179.00 to $160.00 and set a “buy” rating for the company in a research note on Wednesday, February 23rd. SVB Leerink cut their price objective on shares of Agilent Technologies from $175.00 to $145.00 and set an “outperform” rating for the company in a research report on Wednesday, February 23rd. Stifel Nicolaus cut their price objective on shares of Agilent Technologies from $169.00 to $145.00 and set a “hold” rating for the company in a research report on Wednesday, February 23rd. Evercore ISI cut their price target on Agilent Technologies from $170.00 to $155.00 and set an “outperform” rating for the company in a research note on Wednesday, February 23rd. Finally, Robert W. Baird reduced their target price on Agilent Technologies from $170.00 to $161.00 in a report on Wednesday, February 23rd. One research analyst has rated the stock with a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $160.54.

Agilent Technologies Profile (Get Rating)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

Read More

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.